These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

668 related items for PubMed ID: 10804343

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Epidemiological, biological and histological characterization of patients with indeterminate third-generation recombinant immunoblot assay antibody results for hepatitis C virus.
    Ríos M, Diago M, Rivera P, Tuset C, Cors R, García V, Carbonel P, Gonzalez C.
    J Viral Hepat; 2006 Mar; 13(3):177-81. PubMed ID: 16475993
    [Abstract] [Full Text] [Related]

  • 5. Antibodies to hepatitis C virus: a cross-sectional study in patients attending a trauma unit or admitted to hospital for elective surgery.
    García-Bengoechea M, Emparanza JI, Sarriugarte A, Cortés A, Vega JL, González F, Arenas JI.
    Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):237-41. PubMed ID: 7538032
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prevalence, severity, and risk factors of liver disease in blood donors positive in a second-generation anti-hepatitis C virus screening test.
    Serfaty L, Nousbaum JB, Elghouzzi MH, Giral P, Legendre C, Poupon R.
    Hepatology; 1995 Mar; 21(3):725-9. PubMed ID: 7875670
    [Abstract] [Full Text] [Related]

  • 9. Significance of the signal-to-cutoff ratios of anti-hepatitis C virus enzyme immunoassays in screening of Chinese blood donors.
    Ren FR, Lv QS, Zhuang H, Li JJ, Gong XY, Gao GJ, Liu CL, Wang JX, Yao FZ, Zheng YR, Zhu FM, Tiemuer MH, Bai XH, Shan H.
    Transfusion; 2005 Nov; 45(11):1816-22. PubMed ID: 16271110
    [Abstract] [Full Text] [Related]

  • 10. Hepatitis C seroprevalence in accepted versus deferred blood-donor candidates evaluated by medical history and self-exclusion form.
    López RA, Romero-Estrella S, Infante-Ramírez L, Méndez-Aquino JS, Berrón-Ruiz P, Morales-Alfaro NA, Vivar R, Carrada E, Rivera-Rendón Mdel R, Sánchez-Guerrero SA.
    Transfusion; 2004 Sep; 44(9):1344-9. PubMed ID: 15318859
    [Abstract] [Full Text] [Related]

  • 11. Prevalence of hepatitis C virus antibodies and genotypes in asymptomatic, first-time blood donors in Namibia.
    Vardas E, Sitas F, Seidel K, Casteling A, Sim J.
    Bull World Health Organ; 1999 Sep; 77(12):965-72. PubMed ID: 10680243
    [Abstract] [Full Text] [Related]

  • 12. [Hepatitis C virus antibody in the serum of blood donors].
    Barna TK, Ozsvár Z, Szendrényi V, Gál G.
    Orv Hetil; 1996 Mar 10; 137(10):507-11. PubMed ID: 8713664
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of hepatitis B and C and blood donors.
    Mehdi SR, Pophali A, Al-Abdul Rahim KA.
    Saudi Med J; 2000 Oct 10; 21(10):942-4. PubMed ID: 11369958
    [Abstract] [Full Text] [Related]

  • 14. Hepatitis C virus infection among Thai blood donors: antibody prevalence, risk factors and development of risk screening form.
    Luksamijarulkul P, Thammata N, Sujirarat D, Tiloklurs M.
    Southeast Asian J Trop Med Public Health; 2004 Mar 10; 35(1):147-54. PubMed ID: 15272759
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.